HEADER TRANSFERASE, HYDROLASE 05-SEP-05 2AXN TITLE CRYSTAL STRUCTURE OF THE HUMAN INDUCIBLE FORM 6-PHOSPHOFRUCTO-2- TITLE 2 KINASE/FRUCTOSE-2,6-BISPHOSPHATASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BIPHOSPHATASE 3 (6PF- COMPND 3 2-K/FRU- 2,6-P2ASE BRAIN/PLACENTA-TYPE ISOZYME) (IPFK-2) [INCLUDES: COMPND 4 6- PHOSPHOFRUCTO-2-KINASE (EC 2.7.1.105); FRUCTOSE-2,6-BISPHOSPHATASE COMPND 5 (EC 3.1.3.46)]; COMPND 6 CHAIN: A; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PFKFB3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BIFUNCTIONAL ENZYME, EDTA COMPLEX, TRANSFERASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.G.KIM,N.P.MANES,M.R.EL-MAGHRABI,Y.H.LEE REVDAT 6 23-AUG-23 2AXN 1 HETSYN REVDAT 5 29-JUL-20 2AXN 1 COMPND REMARK HETNAM SITE REVDAT 4 09-JUN-09 2AXN 1 REVDAT REVDAT 3 24-FEB-09 2AXN 1 VERSN REVDAT 2 20-JAN-09 2AXN 1 JRNL REVDAT 1 06-DEC-05 2AXN 0 JRNL AUTH S.G.KIM,N.P.MANES,M.R.EL-MAGHRABI,Y.H.LEE JRNL TITL CRYSTAL STRUCTURE OF THE HYPOXIA-INDUCIBLE FORM OF JRNL TITL 2 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE JRNL TITL 3 (PFKFB3): A POSSIBLE NEW TARGET FOR CANCER THERAPY. JRNL REF J.BIOL.CHEM. V. 281 2939 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16316985 JRNL DOI 10.1074/JBC.M511019200 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 44651 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 4459 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3669 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 353 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 45.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2AXN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-SEP-05. REMARK 100 THE DEPOSITION ID IS D_1000034435. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CAMD REMARK 200 BEAMLINE : GCPCC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.3808 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : SILICON CRYSTAL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44651 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.8 REMARK 200 DATA REDUNDANCY : 9.600 REMARK 200 R MERGE (I) : 0.10700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.6 REMARK 200 DATA REDUNDANCY IN SHELL : 9.30 REMARK 200 R MERGE FOR SHELL (I) : 0.68600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB 1K6M REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, ETHYLENE GLYCOL, TRIS, REMARK 280 PHOSHATE, PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 173.22667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 86.61333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 129.92000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 43.30667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 216.53333 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 173.22667 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 86.61333 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 43.30667 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 129.92000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 216.53333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 991 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 PRO A 1 REMARK 465 LYS A 29 REMARK 465 LEU A 30 REMARK 465 THR A 31 REMARK 465 GLU A 446 REMARK 465 ASP A 447 REMARK 465 ALA A 448 REMARK 465 LYS A 449 REMARK 465 LYS A 450 REMARK 465 GLY A 451 REMARK 465 PRO A 452 REMARK 465 VAL A 677 REMARK 465 THR A 678 REMARK 465 PRO A 679 REMARK 465 LEU A 680 REMARK 465 ALA A 681 REMARK 465 SER A 682 REMARK 465 PRO A 683 REMARK 465 GLU A 684 REMARK 465 PRO A 685 REMARK 465 THR A 686 REMARK 465 LYS A 687 REMARK 465 LYS A 688 REMARK 465 PRO A 689 REMARK 465 ARG A 690 REMARK 465 ILE A 691 REMARK 465 ASN A 692 REMARK 465 SER A 693 REMARK 465 PHE A 694 REMARK 465 GLU A 695 REMARK 465 GLU A 696 REMARK 465 HIS A 697 REMARK 465 VAL A 698 REMARK 465 ALA A 699 REMARK 465 SER A 700 REMARK 465 THR A 701 REMARK 465 SER A 702 REMARK 465 ALA A 703 REMARK 465 ALA A 704 REMARK 465 LEU A 705 REMARK 465 PRO A 706 REMARK 465 SER A 707 REMARK 465 CYS A 708 REMARK 465 LEU A 709 REMARK 465 PRO A 710 REMARK 465 PRO A 711 REMARK 465 GLU A 712 REMARK 465 VAL A 713 REMARK 465 PRO A 714 REMARK 465 THR A 715 REMARK 465 GLN A 716 REMARK 465 LEU A 717 REMARK 465 PRO A 718 REMARK 465 GLY A 719 REMARK 465 GLN A 720 REMARK 465 ASN A 721 REMARK 465 MET A 722 REMARK 465 LYS A 723 REMARK 465 GLY A 724 REMARK 465 SER A 725 REMARK 465 ARG A 726 REMARK 465 SER A 727 REMARK 465 SER A 728 REMARK 465 ALA A 729 REMARK 465 ASP A 730 REMARK 465 ARG A 733 REMARK 465 LYS A 734 REMARK 465 HIS A 735 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 25 -72.59 -107.29 REMARK 500 CYS A 26 173.40 100.71 REMARK 500 SER A 33 126.57 -26.92 REMARK 500 LYS A 79 -60.43 69.32 REMARK 500 ASN A 127 46.27 38.36 REMARK 500 LYS A 204 -99.91 -151.30 REMARK 500 ARG A 225 67.17 34.40 REMARK 500 GLU A 330 -11.40 79.26 REMARK 500 ASP A 350 65.03 -152.17 REMARK 500 GLU A 380 -110.19 -111.73 REMARK 500 CYS A 386 -134.76 -133.06 REMARK 500 ALA A 423 -112.82 55.56 REMARK 500 PRO A 454 -63.03 -29.19 REMARK 500 MET A 456 31.11 -98.18 REMARK 500 ASN A 459 94.15 31.35 REMARK 500 REMARK 500 REMARK: NULL DBREF 2AXN A 0 735 UNP Q16875 F263_HUMAN 1 520 SEQRES 1 A 520 MET PRO LEU GLU LEU THR GLN SER ARG VAL GLN LYS ILE SEQRES 2 A 520 TRP VAL PRO VAL ASP HIS ARG PRO SER LEU PRO ARG SER SEQRES 3 A 520 CYS GLY PRO LYS LEU THR ASN SER PRO THR VAL ILE VAL SEQRES 4 A 520 MET VAL GLY LEU PRO ALA ARG GLY LYS THR TYR ILE SER SEQRES 5 A 520 LYS LYS LEU THR ARG TYR LEU ASN TRP ILE GLY VAL PRO SEQRES 6 A 520 THR LYS VAL PHE ASN VAL GLY GLU TYR ARG ARG GLU ALA SEQRES 7 A 520 VAL LYS GLN TYR SER SER TYR ASN PHE PHE ARG PRO ASP SEQRES 8 A 520 ASN GLU GLU ALA MET LYS VAL ARG LYS GLN CYS ALA LEU SEQRES 9 A 520 ALA ALA LEU ARG ASP VAL LYS SER TYR LEU ALA LYS GLU SEQRES 10 A 520 GLY GLY GLN ILE ALA VAL PHE ASP ALA THR ASN THR THR SEQRES 11 A 520 ARG GLU ARG ARG HIS MET ILE LEU HIS PHE ALA LYS GLU SEQRES 12 A 520 ASN ASP PHE LYS ALA PHE PHE ILE GLU SER VAL CYS ASP SEQRES 13 A 520 ASP PRO THR VAL VAL ALA SER ASN ILE MET GLU VAL LYS SEQRES 14 A 520 ILE SER SER PRO ASP TYR LYS ASP CYS ASN SER ALA GLU SEQRES 15 A 520 ALA MET ASP ASP PHE MET LYS ARG ILE SER CYS TYR GLU SEQRES 16 A 520 ALA SER TYR GLN PRO LEU ASP PRO ASP LYS CYS ASP ARG SEQRES 17 A 520 ASP LEU SER LEU ILE LYS VAL ILE ASP VAL GLY ARG ARG SEQRES 18 A 520 PHE LEU VAL ASN ARG VAL GLN ASP HIS ILE GLN SER ARG SEQRES 19 A 520 ILE VAL TYR TYR LEU MET ASN ILE HIS VAL GLN PRO ARG SEQRES 20 A 520 THR ILE TYR LEU CYS ARG HIS GLY GLU ASN GLU HIS ASN SEQRES 21 A 520 LEU GLN GLY ARG ILE GLY GLY ASP SER GLY LEU SER SER SEQRES 22 A 520 ARG GLY LYS LYS PHE ALA SER ALA LEU SER LYS PHE VAL SEQRES 23 A 520 GLU GLU GLN ASN LEU LYS ASP LEU ARG VAL TRP THR SER SEQRES 24 A 520 GLN LEU LYS SER THR ILE GLN THR ALA GLU ALA LEU ARG SEQRES 25 A 520 LEU PRO TYR GLU GLN TRP LYS ALA LEU ASN GLU ILE ASP SEQRES 26 A 520 ALA GLY VAL CYS GLU GLU LEU THR TYR GLU GLU ILE ARG SEQRES 27 A 520 ASP THR TYR PRO GLU GLU TYR ALA LEU ARG GLU GLN ASP SEQRES 28 A 520 LYS TYR TYR TYR ARG TYR PRO THR GLY GLU SER TYR GLN SEQRES 29 A 520 ASP LEU VAL GLN ARG LEU GLU PRO VAL ILE MET GLU LEU SEQRES 30 A 520 GLU ARG GLN GLU ASN VAL LEU VAL ILE CYS HIS GLN ALA SEQRES 31 A 520 VAL LEU ARG CYS LEU LEU ALA TYR PHE LEU ASP LYS SER SEQRES 32 A 520 ALA GLU GLU MET PRO TYR LEU LYS CYS PRO LEU HIS THR SEQRES 33 A 520 VAL LEU LYS LEU THR PRO VAL ALA TYR GLY CYS ARG VAL SEQRES 34 A 520 GLU SER ILE TYR LEU ASN VAL GLU SER VAL CYS THR HIS SEQRES 35 A 520 ARG GLU ARG SER GLU ASP ALA LYS LYS GLY PRO ASN PRO SEQRES 36 A 520 LEU MET ARG ARG ASN SER VAL THR PRO LEU ALA SER PRO SEQRES 37 A 520 GLU PRO THR LYS LYS PRO ARG ILE ASN SER PHE GLU GLU SEQRES 38 A 520 HIS VAL ALA SER THR SER ALA ALA LEU PRO SER CYS LEU SEQRES 39 A 520 PRO PRO GLU VAL PRO THR GLN LEU PRO GLY GLN ASN MET SEQRES 40 A 520 LYS GLY SER ARG SER SER ALA ASP SER SER ARG LYS HIS HET F6P A 736 16 HET EDT A 737 20 HET ADP A 738 27 HETNAM F6P 6-O-PHOSPHONO-BETA-D-FRUCTOFURANOSE HETNAM EDT {[-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-CARBOXYMETHYL- HETNAM 2 EDT AMINO}-ACETIC ACID HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETSYN F6P FRUCTOSE-6-PHOSPHATE; 6-O-PHOSPHONO-BETA-D-FRUCTOSE; 6- HETSYN 2 F6P O-PHOSPHONO-D-FRUCTOSE; 6-O-PHOSPHONO-FRUCTOSE FORMUL 2 F6P C6 H13 O9 P FORMUL 3 EDT C10 H16 N2 O8 FORMUL 4 ADP C10 H15 N5 O10 P2 FORMUL 5 HOH *353(H2 O) HELIX 1 1 GLY A 46 ILE A 61 1 16 HELIX 2 2 VAL A 70 LYS A 79 1 10 HELIX 3 3 SER A 83 ARG A 88 5 6 HELIX 4 4 ASN A 91 GLU A 116 1 26 HELIX 5 5 THR A 129 ASN A 143 1 15 HELIX 6 6 ASP A 156 LYS A 168 1 13 HELIX 7 7 SER A 171 LYS A 175 5 5 HELIX 8 8 ASN A 178 ALA A 195 1 18 HELIX 9 9 ASP A 228 MET A 239 1 12 HELIX 10 10 ASN A 256 GLY A 262 1 7 HELIX 11 11 SER A 271 ASN A 289 1 19 HELIX 12 12 LEU A 300 ALA A 309 1 10 HELIX 13 13 LYS A 318 ASN A 321 5 4 HELIX 14 14 ALA A 325 GLU A 329 5 5 HELIX 15 15 THR A 332 TYR A 340 1 9 HELIX 16 16 TYR A 340 ASP A 350 1 11 HELIX 17 17 SER A 361 GLN A 379 1 19 HELIX 18 18 HIS A 387 LEU A 399 1 13 HELIX 19 19 GLU A 405 LEU A 409 5 5 HELIX 20 20 ASN A 453 ARG A 457 5 5 SHEET 1 A 2 LEU A 4 GLN A 6 0 SHEET 2 A 2 TRP A 13 PRO A 15 -1 O VAL A 14 N THR A 5 SHEET 1 B 6 THR A 65 ASN A 69 0 SHEET 2 B 6 ILE A 120 ASP A 124 1 O VAL A 122 N PHE A 68 SHEET 3 B 6 THR A 35 VAL A 40 1 N ILE A 37 O ALA A 121 SHEET 4 B 6 LYS A 146 VAL A 153 1 O LYS A 146 N VAL A 36 SHEET 5 B 6 SER A 210 ILE A 215 1 O VAL A 214 N GLU A 151 SHEET 6 B 6 ARG A 220 ASN A 224 -1 O ASN A 224 N LEU A 211 SHEET 1 C 6 TYR A 314 GLN A 316 0 SHEET 2 C 6 ARG A 294 THR A 297 1 N THR A 297 O GLU A 315 SHEET 3 C 6 VAL A 382 CYS A 386 1 O ILE A 385 N TRP A 296 SHEET 4 C 6 ILE A 248 ARG A 252 1 N CYS A 251 O CYS A 386 SHEET 5 C 6 THR A 415 VAL A 422 -1 O LEU A 419 N ILE A 248 SHEET 6 C 6 GLY A 425 TYR A 432 -1 O GLU A 429 N LYS A 418 CISPEP 1 GLY A 27 PRO A 28 0 0.78 CRYST1 102.580 102.580 259.840 90.00 90.00 120.00 P 65 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009748 0.005628 0.000000 0.00000 SCALE2 0.000000 0.011257 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003849 0.00000